Ligand validation:4JUL

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4JUL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4JUL_NAG_C_402	43%	32%	0.188	0.914	0.77	2.01	1	8	0	0	100%	0.9333
4JUL_NAG_J_402	28%	64%	0.202	0.852	0.57	0.77	-	-	1	0	100%	0.9333
4JUL_NAG_E_401	20%	40%	0.225	0.824	0.6	1.77	-	3	5	0	100%	0.9333
4JUL_NAG_A_401	16%	47%	0.261	0.835	0.51	1.53	-	2	2	0	100%	0.9333
4JUL_NAG_C_401	7%	43%	0.36	0.824	0.56	1.65	-	5	0	0	100%	0.9333
4JUL_NAG_H_401	7%	47%	0.303	0.754	0.52	1.52	-	2	1	0	100%	0.9333
4JUL_NAG_L_402	7%	44%	0.355	0.802	0.65	1.56	-	3	2	0	100%	0.9333
4JUL_NAG_J_401	2%	54%	0.419	0.72	0.58	1.2	-	1	7	0	100%	0.9333
4CR0_NAG_A_1165	83%	52%	0.112	0.97	0.49	1.37	-	1	0	0	100%	0.9333
4KDQ_NAG_E_502	81%	59%	0.104	0.957	0.53	1.02	-	2	2	0	100%	0.9333
4BH0_NAG_E_1320	80%	61%	0.09	0.938	0.4	1.06	-	1	0	0	100%	0.9333
4K64_NAG_A_601	70%	61%	0.125	0.942	0.51	0.97	-	1	0	0	100%	0.9333
4CQZ_NAG_A_1327	67%	57%	0.112	0.922	0.46	1.16	-	2	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.